1836 related articles for article (PubMed ID: 18077486)
1. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
2. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.
Bosnakovski D; Mizuno M; Kim G; Takagi S; Okumura M; Fujinaga T
Biotechnol Bioeng; 2006 Apr; 93(6):1152-63. PubMed ID: 16470881
[TBL] [Abstract][Full Text] [Related]
3. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15.
Bocelli-Tyndall C; Bracci L; Schaeren S; Feder-Mengus C; Barbero A; Tyndall A; Spagnoli GC
Ann Rheum Dis; 2009 Aug; 68(8):1352-9. PubMed ID: 18647856
[TBL] [Abstract][Full Text] [Related]
4. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts.
Cho ML; Yoon CH; Hwang SY; Park MK; Min SY; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2004 Mar; 50(3):776-84. PubMed ID: 15022319
[TBL] [Abstract][Full Text] [Related]
5. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.
Min DJ; Cho ML; Lee SH; Min SY; Kim WU; Min JK; Park SH; Cho CS; Kim HY
Arthritis Rheum; 2004 Apr; 50(4):1146-55. PubMed ID: 15077296
[TBL] [Abstract][Full Text] [Related]
6. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels.
Nöth U; Rackwitz L; Heymer A; Weber M; Baumann B; Steinert A; Schütze N; Jakob F; Eulert J
J Biomed Mater Res A; 2007 Dec; 83(3):626-35. PubMed ID: 17503531
[TBL] [Abstract][Full Text] [Related]
7. T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis.
Ohnishi Y; Tsutsumi A; Sakamaki T; Sumida T
Int J Mol Med; 2003 Mar; 11(3):331-5. PubMed ID: 12579335
[TBL] [Abstract][Full Text] [Related]
8. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
[TBL] [Abstract][Full Text] [Related]
9. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
10. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis.
Fischer J; Dickhut A; Rickert M; Richter W
Arthritis Rheum; 2010 Sep; 62(9):2696-706. PubMed ID: 20496422
[TBL] [Abstract][Full Text] [Related]
11. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
14. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
15. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
[TBL] [Abstract][Full Text] [Related]
16. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
17. Coculture of equine mesenchymal stem cells and mature equine articular chondrocytes results in improved chondrogenic differentiation of the stem cells.
Lettry V; Hosoya K; Takagi S; Okumura M
Jpn J Vet Res; 2010 May; 58(1):5-15. PubMed ID: 20645581
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.
Ding J; Ghali O; Lencel P; Broux O; Chauveau C; Devedjian JC; Hardouin P; Magne D
Life Sci; 2009 Apr; 84(15-16):499-504. PubMed ID: 19302812
[TBL] [Abstract][Full Text] [Related]
19. In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes.
Chen WH; Lai MT; Wu AT; Wu CC; Gelovani JG; Lin CT; Hung SC; Chiu WT; Deng WP
Arthritis Rheum; 2009 Feb; 60(2):450-9. PubMed ID: 19180515
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
